Pfizer Limited (PFIZER NSE) stock market data APIs
INR5886.1476
-16(-0.3%)
as of July 7, 2025
Try our APIs with
free plan!
Pfizer Limited Financial Data Overview
Price chart is built with
Anychart
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Prev. Close
5886.1476
Open
5870.1474
High
5793.1527
Low
5738.2515
52 wk Range
3701-6451.15
Market Cap
268 539 M
P/E Ratio
34.9238
Shares Outstanding
45 748 K
Revenue
22 813 M
EPS
41
Dividends (Yield)
0.0062
Beta
0.181
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pfizer Limited data using free add-ons & libraries
Get Pfizer Limited Fundamental Data
Pfizer Limited Fundamental data includes:
- Net Revenue: 22 813 M
- EBITDA: 7 402 M
- Earnings Per Share: 168
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-19
- EPS/Forecast: 36.3
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pfizer Limited News
New
U.S. Plans to Shift Bill for Covid Shots and Treatments to Insurers, Patients
The Biden administration is planning for an end to its practice of paying for Covid-19 shots and treatments, shifting more control of pricing and coverage to the healthcare industry in ways that could...
FOCUS-Pfizer vaccine trial bets on early win against coronavirus, documents show
By Marisa Taylor and Dan Levine Sept 17 (Reuters) - Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to th...
FOCUS-Pfizer vaccine trial bets on early win against coronavirus, documents show
By Marisa Taylor and Dan Levine Sept 17 (Reuters) - Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to th...
Some back out of J&J COVID-19 vaccine trial in Spain after AstraZeneca scare, lead investigator says
MADRID, Sept 15 (Reuters) - News of serious side effects in one participant of AstraZeneca's COVID-19 vaccine trial led some volunteers in Johnson & Johnson's vaccine trial in Spain to drop out, its l...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
